Re: OTC Expert & Grey Market Restrictions
in response to
by
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Re: OTC Expert & Grey Market Restrictions
So perhaps tomorrow we'll trade on the Pink Sheets?
https://www.investopedia.com/articles/fundamental-analysis/08/pink-sheets-ottcb.asp#:~:text=OTCBB%20Versus%20Pink%20Sheets,-You%20may%20have&text=The%20OTCBB%20is%20a%20quotation,are%20stricter%20standards%20for%20OTCBB.
"Pink sheet-listed companies do not need to report any information to investors.'
2 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply